---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-033131"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2023-09-20T23:59:59+00:00"
generated_at: "2026-06-10T12:02:37.988378+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Matinas BioPharma updates corporate presentation for investor meetings

## Summary
- Corporate presentation updated as of September 20, 2023 for use at conferences.
- No specific financial or operational details disclosed in the filing body.
- Investors should review the exhibit for any changes to strategy or pipeline.

## SEC filing metadata
- accession: 0001493152-23-033131
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2023-09-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315223033131/0001493152-23-033131-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315223033131/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-033131
- JSON: https://secwatch.observer/filing/0001493152-23-033131.json
- Plain text: https://secwatch.observer/filing/0001493152-23-033131.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.